ACG 2018 Annual Scientific Meeting

Breakfast A: Advances in the Management of Cirrhosis and Portal Hypertension

Moderator: Arun J. Sanyal, MD

• Evaluation of Acute Kidney Injury in a Cirrhotic Patient: HRS and Beyond
  Arun J. Sanyal, MD
  Discuss best practices in the evaluation of acute kidney injury in patients with liver cirrhosis, and guideline recommendations for the management of hepatorenal syndrome.
• Management of Hepatic Encephalopathy
  Catherine T. Frenette, MD
  Apply current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.
• Optimizing Your Patient With Ascites
  Nahum Mendez Sanchez, MD, MSc, PhD, FACG
  Outline a stepwise approach to managing a patient with ascites.

Breakfast B: On the Wards ─ Challenges in the Hospitalized Patient

Moderator: Kathy P. Bull-Henry, MD, FACG

• Refractory Small Bowel Bleeding
  Kathy P. Bull-Henry, MD, FACG
  Describe the approach to management of hospitalized patients with refractory small bowel bleeding.
• Abdominal Pain in Complicated Pancreatitis
  Darwin L. Conwell, MD, MS
  Explain the management of hospitalized patients with complicated pancreatitis, including necrotizing pancreatitis and fluid collections.
• Management of Constipation, Ileus, and Narcotic Bowel
  Melissa Latorre, MD, MS
  Discuss the timely management of hospitalized patients with generalized GI dysmotility with nausea, vomiting, chronic abdominal pain, and constipation.

Breakfast C: Concepts and Controversies in Diverticular Disease

Moderator: Neil H. Stollman MD, FACG

• Acute Diverticulitis: Can We Prevent It, How Best to Treat It, and Can We Decrease Its Recurrence?
  Neil H. Stollman MD, FACG
  Identify risk factors for diverticulitis, possible interventions to prevent and treat it, and the changing role of antibiotics.
• Diverticular Bleeding: Can We Prevent It, How Best to Treat It, and Can We Decrease Its Recurrence?
  Lisa L. Strate, MD, MPH, FACG
  Explain risk factors for diverticular bleeding, as well as possible interventions to prevent and treat it.
• SUDD and SCAD: Are They Entities in Their Own Right, and How Should We Treat Them?
  Brennan M. R. Spiegel, MD, MSHS, FACG
  Discuss the emerging entities of SUDD and SCAD and their possible clinical outcomes and interventions.

Breakfast D: Case-Based Functional GI Testing: Ask the Experts

Moderator: Mark Pimentel, MD, FACG

• Esophageal Motility and pH Testing
  John E. Pandolfino, MD, MSCI, FACG
  Illustrate the key factors related to the performance and interpretation of esophageal motility and pH testing.
• Breath Testing
  Mark Pimentel, MD, FACG
  Summarize the updated consensus recommendations on breath testing and describe clinical applications.
• Pelvic Floor Testing
  Amy E. Foxx-Orenstein, DO, MACG
  Discuss common diagnostic tests and their interpretation for anorectal disorders.

Symposium 1A: Conundrums of the Esophagus

Moderator: Fouad J. Moawad, MD, FACG

• I Think It’s Stuck in My Gullet: Managing Dysphagia
  Ikuo Hirano, MD, FACG
  Discuss the stepwise approach to managing a patient with difficulty swallowing.
• The EoE Spectrum: From the Clinically Responsive to the Refractory Patient
  Fouad J. Moawad, MD, FACG
  Recognize both the medical and endoscopic therapeutic treatment endpoints for EoE.
• PPIs: Friend or Foe?
  Paul Moayyedi, MB ChB, PhD, MPH, FACG
  Identify the risks of long-term PPI use and weigh them against the benefits.

Symposium 1B: Update in CRC Screening

Moderator: Joseph C. Anderson, MD, MHCDS, FACG

• CRC Screening Outside the ASC: Non-Invasive Testing
  Douglas J. Robertson, MD, MPH
  Discuss the performance characteristics of stool (FIT and fecal DNA) and serum-based testing including implications of a positive test and a normal colonoscopy.
• The Cutting Edge of Serrated Polyps
  Joseph C. Anderson, MD, MHCDS, FACG
  Identify the biology, diagnosis, and classification of serrated polyps, as well as optimal detection, resection and surveillance of them.
• Thinking Big About Small Lesions
  Thomas F. Imperiale, MD
  Describe the management of small adenomas including detection, resection, and surveillance, and new concepts such as optical diagnosis and resect and discard.

Symposium 1C: Advances in Non-Alcoholic Fatty Liver Disease (NAFLD)

Moderator: Naga P. Chalasani, MD, FACG

• Initial Work-Up and Evaluation of a Patient With NAFLD
  Naga P. Chalasani, MD, FACG
  Describe an evidence-based approach for the general gastroenterologist in the initial screening, diagnosis, work-up, and staging of patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
• Current Management of NAFLD/NASH: Medical, Endoscopic, and Surgical Therapies
  Zobair M. Younossi, MD, MPH, FACG
  Discuss current guidelines for the management and treatment of non-alcoholic steatohepatitis (NASH), including medical, endoscopic, and surgical therapies.
• Future Therapies for NAFLD/NASH
  Arun J. Sanyal, MD
  Summarize evolving and future strategies for NASH treatment including clinical trial data and implications for clinical practice.

• Plenary Session 1A
• Plenary Session 1B

Symposium 2A: Is There Consensus? Challenging Cases in IBD

Moderator: Sunanda V. Kane, MD, MSPH, FACG

• Managing Ulcerative Colitis in the Sick Outpatient
  Sunanda V. Kane, MD, MSPH, FACG
  Illustrate the importance of a systematic approach to management of complicated ulcerative colitis patients.
• Crohn’s Disease Complicated by an Intraabdominal Abscess – What First? Poke, Prod, or Cut?
  Miguel D. Regueiro, MD, FACG
  Recognize the different approaches to managing the patient with complicated Crohn’s disease.
• Perianal CD – When Anti-TNF Therapy Is Not Enough
  David A. Schwartz, MD, FACG
  Describe the treatment options available for complicated perianal Crohn’s disease.

Symposium 2B: How to Handle Tough Functional Disorders ─ What To Do When Typical Treatments Fail

Moderator: Amy S. Oxentenko, MD, FACG

• Burning, Chest Pain, Nausea, and Vomiting
  John O. Clarke, MD
  Formulate diagnostic and management algorithms for functional upper gastrointestinal symptoms.
• Bloating, Belching, and Abdominal Distention
  Amy S. Oxentenko, MD, FACG
  Summarize different diagnostic and therapeutic approaches in the management of functional excess gas.
• ACG IBS Treatment Monograph: What You Need To Know
  Eamonn M. M. Quigley, MD, MACG
  Discuss current strategies around the diagnosis and management of irritable bowel syndrome.

Symposium 2C: Live From Philadelphia! The 6th Annual Endoscopy Video Forum

Moderators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG

Judges: Douglas G. Adler, MD, FACG, Qiang Cai, MD, PhD, FACG, Laith H. Jamil, MD, FACG, Harshit S. Khara, MD, FACG, Shivangi T. Kothari, MD, FACG, and Reem Z. Sharaiha, MD, MSc